Good overall result and revenue growth for the ZEISS Group
Selasa, 17 Desember 2024 | 20:38
Dr. Karl Lamprecht, President and CEO of the ZEISS Group (Quelle:ZEISS)
OBERKOCHEN, GERMANY - Newsaktuell - 17 December 2024 - ZEISS
Group revenue increased to just under 11 billion euros(10.894 billion
euros), (up 8% on the prior year) – EBIT 1,444 million euros (prior
year: 1,686 million euros, EBIT margin 13%). Mixed development in the
segments. High spend on research and development equivalent to 15% of
revenue, more than 46,000 employees worldwide.
-
- Increasingly challenging market environment for the direct-to-market segments
-
- Strong growth in the Semiconductor Manufacturing Technology segment
-
- Outlook requires reinforcement of resilience measures
Overall, ZEISS can look back on a very successful fiscal year 2023/24.
The Group's revenue rose to 10.894 billion euros (prior year: 10.108
billion euros, up 8%). Earnings before interest and taxes (EBIT) totaled
1.444 billion euros (prior year: 1.686 billion euros) with an EBIT
margin of 13%. All four segments of the ZEISS Group contributed to this
growth. The challenges posed by geopolitical tensions and the current
weaker global economic situation have, however, intensified and impacted
the segments to varying degrees.
"Overall, we ended fiscal year 2023/24 with a good result and revenue
growth. At the same time, it was not possible for all areas to escape
the impact of current developments on the global markets," said Dr. Karl
Lamprecht, President and CEO of ZEISS. "Our success is based on our
enormous innovative strength. To make sure it stays that way, we have
spent a record 15% of revenue on research and development – and thus
more than ever before – and also invested in the targeted expansion of
personnel and infrastructure."
Segment development
|
Revenue (in million euros)
|
|
2023/24
|
2022/23
|
Change
(adjusted for currency effects)
|
Semiconductor Manufacturing Technology
|
4,122
|
3,555
|
16% (16%)
|
Industrial Quality & Research
|
2,369
|
2,295
|
3% (5%)
|
Medical Technology*
|
2,611
|
2,504
|
4% (7%)
|
Consumer Markets
|
1,666
|
1,624
|
3% (4%)
|
BERITA LAINNYA
BERIKAN KOMENTAR